Table II.
Study | No. | Persistence Rate (%) | ||||
---|---|---|---|---|---|---|
Diuretic | β‐Blocker | CCB | ACEI | ARB | ||
1 Year | ||||||
Bloom 1998 42 | 21,723 | 38 | 43 | 50 | 58 | 64 |
Conlin 2001 39 | 15,175 | 21 | 46 | 54 | 61 | 67 |
Hasford 2002 21 | 2,416 | 34 | 50 | 44 | 42 | 51 |
Bourgault 2005 17 | 21,326 | 45 | 50 | 55 | 59 | 66 |
Erkens 2005 43 | 2,243 | 33 | 35 | 35 | 60 | 62 |
Perreault 2005 18 | 14,947 | 61 | 68 | 68 | 71 | 73 |
Hoer 2007 37 | 62,745 | 26 | 14 | 34 | 34 | 53 |
Patel 2007 44 | 242,882 | 30 | 40 | 38 | 48 | 52 |
Elliott 2007 45 | 60,685 | 56 | – | 60 | 65 | 69 |
3 Years | ||||||
Bourgault 2005 17 | 21,326 | 29 | 34 | 38 | 40 | 53 |
Hasford 2007 38 | 13,763 | 9 | 13 | 12 | 14 | 11 |
Perreault 2005 17 | 21,011 | 48 | 57 | 58 | 58 | 59 |
4 Years | ||||||
Burke 2006 41 | 109,454 | 31 | 33 | 35 | 40 | 42 |
Conlin 2001 39 | 15,175 | 16 | 35 | 41 | 46 | 51 |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker.